#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glomerulonephritis membranous Uveal melanoma Osteomyelitis Neuroblastoma Primary myelofibrosis Polycythaemia vera Iron overload Hypochromic anaemia Red blood cell abnormality Demyelination Neonatal alloimmune thrombocytopenia Rett syndrome Meningitis meningococcal Leukoencephalopathy Neuronal ceroid lipofuscinosis More trials…

    Learn about Rare Diseases

    Choroid melanoma – Diagnostics Friedreich’s ataxia – Basic Information Inclusion body myositis – Trials in Disease Ehlers-Danlos syndrome – Trials in Disease Crigler-Najjar syndrome – Treatment Gastrointestinal stromal tumour – Diagnostics Gaucher’s disease type I – Life with Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Treatment Glycogen storage disease type II Angiosarcoma recurrent – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Calcium Oxybate Vosoritide Phenazone ALN-961583 Human Coagulation Factor Viii Temozolomide ZUNIBERGENE ROCPARVOVEC GSKVX000000034795 Db-1303 Flecainide Apixaban Brodalumab Trientine Dihydrochloride Retinol Palmitate ROC-101 HYDROCHLORIDE Tryptophan Brepocitinib Tosilate Sabatolimab Nebivolol Hydrochloride Zibotentan More therapies…

    Learn about Your Condition

    Dry eye Marfan's syndrome Neurodegenerative disorder Scoliosis Anaemia Primary hyperoxaluria Wolfram syndrome Peripheral spondyloarthritis Bile acid synthesis disorder Habitual abortion Metachromatic leukodystrophy Haemorrhage prophylaxis Thrombotic microangiopathy Complicated appendicitis Thrombocytosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • Study comparing empasiprubart versus intravenous immunoglobulin for treating adults with multifocal motor neuropathy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Multifocal motor neuropathy
    Investigated Drugs:
    • Empasiprubart
    • Human Normal Immunoglobulin (Iv)
    Austria Belgium Czechia Denmark Estonia France +13

  • Study on How Tafamidis is Absorbed in the Blood of Healthy Adults with Transthyretin Amyloid Cardiomyopathy

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Amyloidosis
    • Cardiac amyloidosis
    Investigated Drugs:
    • Tafamidis
    Belgium

  • Study on the Effectiveness of Diclofenac Gel AMZ001 for Treating Knee Osteoarthritis Pain in Adults

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Paracetamol
    Czechia Denmark Poland

  • Study of Retatrutide for Patients with Obesity, Overweight, and Chronic Low Back Pain

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Back pain
    • Obesity
    • Overweight
    Investigated Drugs:
    • Ly3437943 Sodium
    Poland

  • Title: Long-term safety and effectiveness study of Ulviprubart in patients with inclusion body myositis who completed previous treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Inclusion body myositis
    Investigated Drugs:
    • ULVIPRUBART
    Belgium France Germany

  • Study on the Effects of LNA043 for Patients with Knee Osteoarthritis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Lna043
    Czechia Denmark Estonia Poland Spain
Previous Page
1 … 40 41 42 43 44 … 67
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!